RAD December 2023 Abstracts and Posters
All accepted abstracts will be published in The British Journal of Dermatology.552 - Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis
Raj Chovatiya, Andreas Wollenberg, Simone Ribero, Hidehisa Saeki, Christian B Øland, Louise A Steffensen, Ann-Marie Tindberg, Jacob P Thyssen, Andrew Blauvelt
553 - Tralokinumab real-world patient-reported outcomes in moderate-to-severe atopic dermatitis adult patients in the United States: 6-month interim analysis
Peter Lio, Yestle Kim, Sanjeev Balu, Halley Costantino, Dawn Bates, Cassandra Rene, Amanda Lopez, Jennifer Soung
554 - Real-world evidence demonstrating tralokinumab onset of action and efficacy in two skin of color patients with moderate-to-severe atopic dermatitis
Daniel Tinker and Duane Dilworth
555 - Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials
Kristian Reich, Richard G Langley, Juan Francisco Silvestre, Delphine Staumont-Salle, Antonio Costanzo, Andrew Pink, Amy Paller, Norito Katoh, Andreas Wollenberg, Richard B Warren, Christian Bjerregård Øland, Ann-Marie Tindberg, Le Gjerum, Eric Simpson
556 - A global, observational, cohort study of patients with atopic dermatitis to evaluate tralokinumab real-world clinical use (TRACE): baseline characteristics from the first 100 patients in Germany
Diamant Thaçi, Andreas Kleinheinz, Dimitra Maria Anastasiadou, John Stinson, April W. Armstrong
557 - Tralokinumab real-world use in adults with atopic dermatitis: baseline characteristics of the first 100 patients recruited to the TRACE study in the United States
April W. Armstrong, Cory Rubin, Abel Jarell, Tien Nguyen, Jerry Bagel, John Stinson, Shannon Schneider, Dimitra M. Anastasiadou, Adrian Rodriguez
561 - Dupilumab treatment reduces signs in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial
Eric L. Simpson, Weily Soong, Margitta Worm, Andreas Pinter, Koji Masuda, Liyang Shao, Ariane Dubost-Brama, Ashish Bansal, Andrew Korotzer, Ana B. Rossi
562 - Dupilumab treatment provides long-term improvement in itch in pediatric patients with moderate-to-severe atopic dermatitis over 1 year
Elaine Siegfried, Eric L. Simpson, Mark Boguniewicz, Carsten Flohr, Lawrence F. Eichenfield, Andreas Pinter, Michele Ramien, Xing-Hua Gao, Zhen Chen, Lauren Bates, Ana B. Rossi
563 - Dupilumab improves skin lipid composition in atopic dermatitis irrespective of patient filaggrin (FLG) mutation status
Evgeny Berdyshev, Elena Goleva, Anna-Sofia Bronoff, Brittany N. Richers, Shannon Garcia, Marco Ramírez-Gama, Patricia Taylor, Robert Bissonnette, Joseph Zahn, Inoncent Agueusop, Shantanu Bafna, Mark Boguniewicz, Annie Zhang
564 - Conjunctivitis adverse events in dupilumab clinical trials
Matthew Zirwas, Raj Chovatiya, Linda Stein Gold, Brad Shumel, Amy Praestgaard, Zhen Chen, Tayler Gonzalez, Guy Gherardi, Emma Lawless